By Catherine Eckford (European Pharmaceutical Review)2025-03-12T17:43:52
Investment in the new manufacturing plant strengthens Merck (MSD)’s vaccine production capacity in the US.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-27T15:37:00
Sponsored by IMA Pharma
2025-12-03T07:58:01
Sponsored by MBV AG
2025-07-02T13:00:00
Sponsored by Thermo Fisher Scientific
2025-09-19T15:46:00
Sponsored by ACCI, By European Pharmaceutical Review
2026-04-15T15:00:00 2026-04-15T16:00:00
Sponsored by Thermo Fisher Scientific
2026-02-25T15:00:00
Sponsored by Particle Measuring Systems
Site powered by Webvision Cloud